# Hitting the Mark: Introducing State-of-the-art MRI for Precision Radiotherapy of Glioblastoma

> **NCT06183983** · NA · RECRUITING · sponsor: **Erasmus Medical Center** · enrollment: 53 (estimated)

## Conditions studied

- Glioblastoma

## Interventions

- **DIAGNOSTIC_TEST:** Extended or additional MRI-scan (with contrast) prior to radiotherapy

## Key facts

- **NCT ID:** NCT06183983
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-03
- **Primary completion:** 2025-08
- **Final completion:** 2026-08
- **Target enrollment:** 53 (ESTIMATED)
- **Last updated:** 2025-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06183983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06183983, "Hitting the Mark: Introducing State-of-the-art MRI for Precision Radiotherapy of Glioblastoma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06183983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*